- Home
- BACK vs BJDX Comparison
BACK vs BJDX Comparison
Compare BACK & BJDX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BACK
- BJDX
- Stock Information
- Founded
- BACK 2000
- BJDX 2015
- Country
- BACK United States
- BJDX United States
- Employees
- BACK N/A
- BJDX N/A
- Industry
- BACK Medical Specialities
- BJDX Medical Specialities
- Sector
- BACK Health Care
- BJDX Health Care
- Exchange
- BACK Nasdaq
- BJDX Nasdaq
- Market Cap
- BACK 2.2M
- BJDX 1.8M
- IPO Year
- BACK 2019
- BJDX 2021
- Fundamental
- Price
- BACK $1.10
- BJDX $4.05
- Analyst Decision
- BACK
- BJDX
- Analyst Count
- BACK 0
- BJDX 0
- Target Price
- BACK N/A
- BJDX N/A
- AVG Volume (30 Days)
- BACK 23.2K
- BJDX 959.8K
- Earning Date
- BACK 12-31-2024
- BJDX 11-07-2024
- Dividend Yield
- BACK N/A
- BJDX N/A
- EPS Growth
- BACK N/A
- BJDX N/A
- EPS
- BACK N/A
- BJDX N/A
- Revenue
- BACK N/A
- BJDX N/A
- Revenue This Year
- BACK N/A
- BJDX N/A
- Revenue Next Year
- BACK N/A
- BJDX N/A
- P/E Ratio
- BACK N/A
- BJDX N/A
- Revenue Growth
- BACK N/A
- BJDX N/A
- 52 Week Low
- BACK $0.98
- BJDX $3.03
- 52 Week High
- BACK $7.75
- BJDX $1,272.00
- Technical
- Relative Strength Index (RSI)
- BACK 45.18
- BJDX 48.88
- Support Level
- BACK $1.06
- BJDX $4.30
- Resistance Level
- BACK $1.21
- BJDX $5.49
- Average True Range (ATR)
- BACK 0.10
- BJDX 0.67
- MACD
- BACK 0.01
- BJDX 0.11
- Stochastic Oscillator
- BACK 29.17
- BJDX 25.52
About BACK IMAC Holdings Inc.
IMAC Holdings Inc is a provider and manager of value-based, conservative medical care combining life science advancements with traditional medical care for movement-restricting diseases and conditions in IMAC Regeneration Centers and BackSpace clinics. Its Innovative Medical Advancements and Care (IMAC) Regeneration Centers combine medical and physical procedures to improve patient experiences and outcomes and reduce healthcare costs as compared to other available treatment options.
About BJDX Bluejay Diagnostics Inc.
Bluejay Diagnostics Inc is a medical diagnostics company. It is developing rapid tests using whole blood using its Symphony technology platform to improve patient outcomes in critical care settings. The company's first product, the Symphony IL-6 test, is for the monitoring of disease progression in critical care settings and is a clinically established inflammatory biomarker for the assessment of the severity of infection and inflammation across many disease indications, including sepsis.